Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a See-Through tube make lung surgery safer?

NCT ID NCT07362797

Knowledge-focused Sponsor: Diansan Su Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 18, 2026 · Updated 5 times

Summary

This study compares a new visual double-lumen tube to a standard tube for lung surgery. It aims to see if the visual tube helps doctors place it correctly on the first try and reduces complications. 500 adults having lung surgery will be randomly assigned to one tube type. The goal is to improve safety and efficiency during surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 566 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

\*\*Inclusion Criteria:\*\* 1. Adults aged 18 years or older. 2. American Society of Anesthesiologists physical status I-III. 3. Scheduled for elective thoracoscopic surgery requiring one-lung ventilation with a right-sided double-lumen tube. 4. Able to provide written informed consent. \*\*Exclusion Criteria:\*\* 1. Contraindication to placement of a right-sided double-lumen tube, including a lesion involving the right main bronchus that precludes its use. 2. Known tracheobronchial anatomical abnormality that may interfere with right-sided double-lumen tube placement or lung isolation. 3. Known or anticipated difficult airway. 4. Requirement for rapid-sequence induction. 5. Emergency surgery. 6. Severe respiratory instability that, in the investigator's judgement, makes participation unsafe. 7. Concurrent participation in another interventional clinical trial that could interfere with the present study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Double lumen tube intubation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Double lumen tube intubation One-lung ventilation Thoracoscopic surgery

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Affiliated Hospital of Jiaxing University（The First Hospital of Jiaxing）

    RECRUITING

    Jiaxing, Zhejiang, 314000, China

  • The First Affiliated Hospital, Zhejiang University School of Medicine,

    RECRUITING

    Hangzhou, Zhejiang, 310000, China

  • The Second Affiliated Hospital of Jiaxing University（The Second Hospital of Jiaxing）

    NOT_YET_RECRUITING

    Jiaxing, Zhejiang, 314000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.